Evaluation of SAR440340 and as Combination Therapy With Dupilumab in Moderate-to-Severe Asthma Participants
Clinical trial NCT03387852 · COMPLETED
Trial details
- NCT number
- NCT03387852
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-12
- Primary completion
- 2019-03-21
- Enrollment
- 296
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.